From:  Exploring the therapeutic utility of apocynin in multifactorial neurodegenerative Alzheimer’s disease in a preclinical animal model

 Animal groups and treatments for Aβ142 induced AD model.

GroupTreatmentNo. of Animals
1.SC: sham control group received → saline solution only12
2.142: negative control (NC) group received → Aβ1–42 (2 µL, 200 µmol/L) intrahippocampally12
3.AL: apocynin low dose received → Aβ1–42 (2 µL, 200 µmol/L) intrahippocampally + apocynin low (50 mg/kg) p.o.12
4.AM: apocynin medium dose received → Aβ1–42 (2 µL, 200 µmol/L) intrahippocampally + apocynin medium (150 mg/kg) p.o.12
5.AH: apocynin high dose received → Aβ1–42 (2 µL, 200 µmol/L) intrahippocampally + apocynin high (300 mg/kg) p.o.12
6.STD: standard treatment received → Aβ1–42 (2 µL, 200 µmol/L) intrahippocampally + standard donepezil (DON) 5 mg/kg p.o.12